Doximity (DOCS) reported fiscal Q1 non-GAAP earnings Thursday of $0.36 per diluted share, up from $0.28 a year earlier.
Analysts polled by FactSet expected $0.30.
Revenue for the quarter ended June 30 was $145.9 million, up from $126.7 million a year earlier.
Analysts surveyed by FactSet expected $139.5 million.
The company expects fiscal Q2 revenue of $157 million to $158 million.
Analysts expect $150.2 million.
The company now expects fiscal 2026 revenue of $628 million to $636 million, up from the previous guidance of $619 million to $631 million.
Analysts surveyed by FactSet expect $626.5 million.
Separately, Doximity said Thursday it acquired Pathway Medical.
The deal closed on July 29 for a cash consideration of $26 million and up to $37 million in additional equity grants, according to the company.
Doximity shares were up nearly 7% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.